Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Post by Mouloukon Jun 01, 2016 10:49am
221 Views
Post# 24922946

Too optimistic?

Too optimistic?With the ITA submission hopefully filled by June 15 (previously in May) and approval obtained by the end of the month (even though July is usually a vacation period for many workers), I was expecting way more speculation than that. I was also hoping to see $2 to $3 a share right after the approval, but I guess that my expectations were too high. With all the delays, I guess that investors will be more patient before jumping in and will want to see actual results. I was initially hoping to see the ITA approval by the end of 2015 and here we are, still waiting for the final submission to HC from TLT. I still hope that 2016 will go as planned, as my investment will finally take off. But as I see the time passing, the summer that will slow things down, I keep wondering if 2016 is not too optimistic. Moulouk
Bullboard Posts